pharma · infections · Not applicable (submitted trial is a BE study in healthy participants)
Zaklady FarmaFarmaceutyczne Polpharma
Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
Zaklady FarmaFarmaceutyczne Polpharma is a pharma organization headquartered in EU. Primary therapeutic focus areas include infections, Not applicable (submitted trial is a BE study in healthy participants), infection. N
Company details
- Status
- Public
- HQ
- EU
- Programs
- 6
- Drugs
- 15
- Patents
- 0
01-DAP-BIO-24
Phase 1 · other · intended for treatment of for the treatment of (2): • insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise. • symptomatic chronic heart failure. • chronic kidney disease.
01-DAP-BIO-24 for intended for treatment of for the treatment of (2): • insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise. • symptomatic chronic heart failure. • chronic kidney disease. is a Phase 1 program (other) at Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. with 1 ClinicalTrials.gov record(s).
Internal code 01-DAP-BIO-24
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
- Phase
- Phase 1
- Modality
- other
- Indication
- intended for treatment of for the treatment of (2): • insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise. • symptomatic chronic heart failure. • chronic kidney disease.
- Status
- active
- Trials
- 1